CARDiac Toxicity Following ImmunOtherapy Treatment for Melanoma

NCT06605833 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Melanoma Stage III or IV

Interventions

DIAGNOSTIC_TEST: 12-Lead ECG
DIAGNOSTIC_TEST: Transthoracic Echocardiogram
DIAGNOSTIC_TEST: Cardiac MRI
DIAGNOSTIC_TEST: Cardiac Biomarker Screening
OTHER: Basic Observations

Sponsor

Royal Marsden NHS Foundation Trust

Collaborators

[object Object]
[object Object]